Navigation Links
Will 'botox' be the aspirin of the 21st century?
Date:3/18/2008

Oxford, UK 25 March 2008 The journal Medical Hypotheses (http://www.elsevier.com/locate/mehy), an Elsevier publication, has announced the winner of the 2007 David Horrobin Prize for medical theory. Written by Erle CH Lim and Raymond CS Seet of the Yong Loo Lin School of Medicine, National University of Singapore, the article, Botulinum toxin, Quo Vadis? was judged to best embody the spirit of the journal.

Botulinum toxin (botox) is a very powerful and often fatal poison produced by a rare type of food poisoning bacteria. The toxin blocks the activity of cholinergic nerves which control muscles and glands, causing glands to stop secretion and muscles to become paralysed. But in tiny doses and applied to specific structures, botox has many medical uses. Lim and Seets paper describes the early medical use of botulinum toxin in treating eye-squint, then its wider role in treating pain, excess glandular secretion and muscle spasm disorders, and its best-known use as a wrinkle remover in cosmetic surgery.

The authors go on to suggest a wide range of possible uses for botox such as calming restless legs, improving breathing in asthma, reducing sweating, and performing a chemical liposuction by removing excessive fat. In theory, botulinum toxin might be used to treat a broad range of pain syndromes, and to reduce activity for all types of glands and muscles that receive their nerve supply from the cholinergic system.

This judge for this years prize was the internationally famous neuroscientist VS Ramachandran of the University of California at San Diego, USA. Professor Ramachandran described the paper as: "A scholarly overview containing many suggestions for potentially valuable new directions of research"

The 1,000 prize was launched in 2004 and is awarded annually by Elsevier, the publisher of Medical Hypotheses. It is named in honour of Dr. David Horrobin, the renowned researcher, biotechnology expert and founder of Medical Hypotheses, who died in 2003.


'/>"/>

Contact: Ian Salusbury
ian.salusbury@elsevier.com
44-186-584-3824
Elsevier
Source:Eurekalert

Related medicine news :

1. GFX: Wrinkle-Killer or Botox(R) Hit-Man?
2. Founding Father of Modern Cosmetic Dermatology Seeks to Warn Public of Misrepresented Data and Inappropriate Use of Botox
3. Clarity for Consumers on Botox Complication and Death Reports
4. AAFPRS Speaks to the Safety of BOTOX(R) Cosmetic
5. Botox Cosmetic Alternatives Are Available: Surgical Procedures Offer Solution for Wrinkles
6. FDA Warns of Childrens Deaths Linked to Botox
7. The American Society for Aesthetic Plastic Surgery Addresses the Safety of Botox
8. American Society for Dermatologic Surgery Supports Current Labeling of Allergans Botox(R) Products
9. ASPS Addresses Concerns Regarding BOTOX Treatments
10. Men need more Botox than women
11. UT Southwestern urologist uses Botox to treat debilitating condition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... ... The Global Wellness Summit (GWS), an annual conference for international ... travel, spa and beauty in Europe. The organization asked its partner experts in Europe ... researchers - to forecast where wellness is headed in Europe. Predictions range from European ...
(Date:5/31/2016)... IL (PRWEB) , ... May 31, 2016 , ... The ... and executive committee members: , David G. Lewallen, MD, began his term as ... past president. Michael L. Parks, MD, is OREF’s new president-elect. Richard F. Kyle, MD, ...
(Date:5/31/2016)... ... May 31, 2016 , ... In a recent interview on ... broadcast on New Rochelle, NY-based WVOX (1460 AM), leading medical insurance advocate ... calls the country’s “modern medical money maelstrom.” , During the interview with Mr. ...
(Date:5/31/2016)... , ... May 31, 2016 , ... ... apply information technology solutions to the healthcare industry, The University of Scranton is ... offers an accelerated path to a career in rapidly growing field of healthcare ...
(Date:5/30/2016)... ... May 30, 2016 , ... "This plugin comes with ... Austin - CEO of Pixel Film Studios. , TransPack Volume 7 features ... Choose from abstract transitions to more simple wipes with blur & drop shadow ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 26, 2016   Change Healthcare , ... network solutions and technology-enabled services designed to ... into a strategic channel partnership with SourceMed, ... solutions and revenue cycle management services that ... rehabilitation clinics to optimize revenue, operational efficiency ...
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... Deutschland und GERMANTOWN, Maryland , ... Zusammenarbeit mit Therawis bedient dringenden ...   QIAGEN N.V. (NASDAQ: ... bekannt, eine Lizenz- und Entwicklungsvereinbarung mit Therawis Diagnostics ... die Onkologie eingegangen zu sein. Ein erstes Projekt ...
Breaking Medicine Technology: